Efficacia e tollerabilità dell'Oxcarbazepina nel trattamento dell'epilessia tumorale

Translated title of the contribution: Efficacy and tolerability of Oxcarbazepine in brain tumours and epilepsy

A. Zarabla, M. Maschio, L. Dinapoli, A. Fabi, A. Mirri, A. Pace, C. M. Carapella, A. Pompili, E. Occhipinti, B. Jandolo

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this retrospective study was to investigate the safety and efficacy of Oxcarbazepine (OXC) in monotherapy in patients with brain tumour and epilepsy. We studied 21 patients; in 8 patients OXC was the first therapeutic choice, in 13 it substituted the first therapy. Oxcarbazepine induced no side effects. OXC induced a complete seizures control in 14 patients, a seizures rate reduction higher than 50% in 4 patients, an unmodified seizures rate in 2 patients. These preliminary data seem to indicate that OXC treatment in patients with brain tumours is quite safe and effective.

Translated title of the contributionEfficacy and tolerability of Oxcarbazepine in brain tumours and epilepsy
Original languageItalian
Pages (from-to)261-262
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number133-134
Publication statusPublished - Jul 2006

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Efficacy and tolerability of Oxcarbazepine in brain tumours and epilepsy'. Together they form a unique fingerprint.

Cite this